DuraGen® Plus - DuraGen Plus™ Dural Regeneration Matrix is an - Integra Lifesciences Corporation

Duns Number:083171244

Device Description: DuraGen Plus™ Dural Regeneration Matrix is an absorbable implant for repair of dural defec DuraGen Plus™ Dural Regeneration Matrix is an absorbable implant for repair of dural defects. DuraGen Plus™ is an easy to handle, soft, white, pliable, nonfriable, porous collagen matrix. DuraGen Plus™ is supplied sterile, nonpyrogenic, for single use in double peel packages in a variety of sizes.

Want to know more about this Product? Request more information now!


More Product Details

Catalog Number

DP-1045

Brand Name

DuraGen® Plus

Version/Model Number

DP1045

Device Commercial Distribution Status

In Commercial Distribution

Commercial Distribution End Date

-

Issuing Agency

In GS1

Product Characteristics

MRI safety Status

Labeling does not contain MRI Safety Information

Device required to be labeled as containing natural rubber latex or dry natural rubber (21 CFR 801.437)

-

Device labeled as "Not made with natural rubber latex"

-

For Single-Use

Yes

Prescription Use (Rx)

Yes

Over the Counter (OTC)

-

Kit

-

Combination Product

-

Human Cell, Tissue or Cellular or Tissue-Based Product (HCT/P)

-

FDA Premarket Submission

K032693

Product Code Details

Product Code

GXQ

Product Code Name

DURA SUBSTITUTE

Device Record Status

Public Device Record Key

10fa02c6-9a23-4bf0-b17b-c7dd551cc272

Public Version Date

October 26, 2022

Public Version Number

7

DI Record Publish Date

September 22, 2015

Additional Identifiers

Package DI Number

None

Quantity per Package

-

Contains DI Package

-

Package Discontinue Date

-

Package Status

-

Package Type

-

"INTEGRA LIFESCIENCES CORPORATION" Characteristics
Device Class Device Class Description No of Devices
1 A medical device with low to moderate risk that requires general controls 14
2 A medical device with a moderate to high risk that requires special controls. 75
3 A medical device with high risk that requires premarket approval 17
U Unclassified 32